Small intestine adenocarcinoma is a rare type of cancer that develops in glandular cells lining the small intestine, making up only a small fraction of digestive system cancers. Because it often shows no symptoms in its early stages and the small intestine is not routinely screened, diagnosis typically happens after the disease has already progressed, posing significant challenges for both patients and doctors.

Introduction: Who Should Undergo Diagnostics

Diagnosing small intestine adenocarcinoma can be quite difficult because the small intestine is not a body part that gets routinely checked or screened, unlike the colon where regular colonoscopies are common practice. Many people with this type of cancer experience no symptoms during the early stages of the disease, which means they may not realize anything is wrong until the cancer has grown or spread.^[1]

When symptoms do appear, they tend to be vague and could point to many different digestive system problems, making it hard to pinpoint small intestine cancer as the cause right away. This vagueness often leads to delays in getting the right diagnosis.^[2]

Anyone experiencing persistent digestive symptoms should seek medical attention, especially if these issues don’t go away or get worse over time. Symptoms that should prompt you to see a doctor include ongoing pain or cramps in the middle part of your belly, unexplained weight loss without trying to lose weight, blood appearing in your bowel movements (which might look red or black), nausea and vomiting, diarrhea, bloating, indigestion, or a noticeable lump in your abdomen.^[1][7]

People who have certain health conditions are at higher risk for developing small intestine adenocarcinoma and may need to be more vigilant about symptoms. These conditions include Crohn’s disease, which is a type of inflammatory bowel disease that causes chronic inflammation of the digestive tract. Those with celiac disease, an autoimmune disorder triggered by eating gluten, also face increased risk. Familial adenomatous polyposis, or FAP, is an inherited condition that causes numerous polyps to form in the digestive tract and significantly raises the risk of various cancers, including small intestine adenocarcinoma.^[3][5]

Additionally, people who eat diets high in red meat or saturated fat, those who smoke, and those who consume alcohol regularly may have a higher chance of developing this cancer. Chronic inflammation within the small intestine, from whatever cause, is believed to lead to cell changes that can eventually become cancerous.^[1]

Because small intestine cancer is more common in men than in women and is typically diagnosed in people aged 65 and older, these groups should be particularly attentive to any unusual digestive symptoms.^[1]

Diagnostic Methods for Small Intestine Adenocarcinoma

When doctors suspect small intestine adenocarcinoma, they use a combination of different tests and procedures to confirm the diagnosis and understand how far the cancer may have spread. Because this cancer is so rare and the small intestine is difficult to examine, diagnosing it often requires multiple steps and various types of testing.^[15]

Physical Examination and Medical History

The diagnostic process usually begins with a thorough physical examination. Your doctor will ask about your health history, including any past illnesses, current symptoms, and health habits such as diet, smoking, and alcohol use. During the physical exam, the doctor will check your abdomen for swelling, lumps, or areas of tenderness. They may also examine your eyes and skin for signs of jaundice, which appears as a yellow discoloration and can suggest that cancer has spread to the liver or is blocking bile ducts.^[16][23]

Blood Tests

While blood tests cannot directly detect small intestine cancer, they provide important clues about your overall health and may suggest problems that warrant further investigation. A complete blood count, or CBC, checks the levels of different types of cells in your blood. If your red blood cell count is low, a condition called anemia, it might indicate bleeding somewhere in your digestive system, including the small intestine.^[15][21]

Other blood tests can assess how well your organs, particularly your liver and kidneys, are functioning. Abnormal results on liver function tests might suggest that cancer has spread to the liver. Some doctors may also check levels of carcinoembryonic antigen, or CEA, a substance that can be elevated in people with certain cancers, although this is not specific to small intestine cancer alone.^[21]

Imaging Tests

Imaging tests create detailed pictures of the inside of your body, helping doctors locate tumors and determine their size and whether the cancer has spread to other areas. Several types of imaging may be used in diagnosing small intestine adenocarcinoma.^[15][21]

Computed tomography, commonly known as a CT scan, uses X-rays taken from different angles and computer processing to create cross-sectional images of your body. CT scans can show the small intestine as well as nearby organs, lymph nodes, and other tissues, helping doctors see if cancer has spread beyond the original site.^[21]

Magnetic resonance imaging, or MRI, uses powerful magnets and radio waves instead of X-rays to create detailed images of soft tissues inside the body. MRI scans can be particularly useful for examining the small intestine and surrounding structures.^[21]

Positron emission tomography, known as a PET scan, involves injecting a small amount of radioactive sugar into the body. Cancer cells, which use more energy than normal cells, absorb more of this sugar and show up as brighter spots on the scan. PET scans can help identify cancer that has spread to distant parts of the body.^[21]

Procedures to Examine the Small Intestine

Because the small intestine is long, coiled, and located deep within the abdomen, it cannot be examined with a simple test. Several specialized procedures allow doctors to look inside the small intestine directly, and often a tissue sample can be collected during these procedures.^[15][21]

Upper endoscopy, also called esophagogastroduodenoscopy or EGD, is a procedure where a thin, flexible tube with a light and camera on the end is inserted through your mouth, down your throat, and into your stomach and the first part of the small intestine called the duodenum. This allows the doctor to directly see the lining of these organs and take small tissue samples if needed. Since most small intestine adenocarcinomas occur in the duodenum, upper endoscopy is often very useful for diagnosis.^[15][21]

Capsule endoscopy involves swallowing a small pill-sized camera that takes thousands of pictures as it travels through your digestive tract. The images are transmitted to a recorder you wear on a belt. This method can examine parts of the small intestine that are beyond the reach of a standard endoscope. However, it cannot take tissue samples, so if something suspicious is found, additional procedures may be needed.^[15]

Double-balloon enteroscopy or push enteroscopy are more advanced techniques that allow doctors to reach deeper into the small intestine than a standard upper endoscopy. These procedures use special scopes with balloons that can be inflated to help advance the scope further into the intestine. Tissue samples can be taken during these procedures.^[15][21]

Biopsy

A biopsy is the removal of a small piece of tissue for examination under a microscope. It is the only definitive way to confirm whether cancer is present. The tissue sample might be obtained during one of the endoscopy procedures described above, using special instruments passed through the scope to snip or cut a small piece of suspicious tissue.^[15][21]

In some cases, surgery may be required to obtain a biopsy if the tumor cannot be reached with an endoscope or if imaging tests suggest cancer but direct visualization is difficult. Once the tissue sample is obtained, a specialist called a pathologist examines it under a microscope to look for cancer cells. Additional tests on the tissue can provide more information about the specific characteristics of the cancer cells, which helps guide treatment decisions.^[15][21]

Staging

Staging is the process of determining how much cancer is in the body and where it is located. Knowing the stage of cancer helps doctors plan the most appropriate treatment. Many of the same tests used to diagnose small intestine adenocarcinoma are also used to stage the disease.^[3][10]

During staging, doctors look to see if cancer cells have spread within the small intestine, to nearby lymph nodes (small bean-shaped organs that are part of the immune system), or to distant organs such as the liver or lungs. Understanding the stage of the cancer is crucial for planning treatment, as localized cancers that haven’t spread may be treated differently than cancers that have metastasized, or spread, to other parts of the body.^[3][10]

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments or new ways of using existing treatments. For patients with small intestine adenocarcinoma, participating in a clinical trial may provide access to promising new therapies that are not yet widely available. However, not everyone can join every clinical trial. Researchers use specific criteria to determine which patients are eligible to participate, and these criteria often include certain diagnostic tests and measurements.^[12]

Before a patient can enroll in a clinical trial for small intestine adenocarcinoma, they typically need to undergo a series of diagnostic evaluations to confirm they meet the study’s requirements. These requirements are designed to ensure that the trial results will be meaningful and that participants will be as safe as possible.^[12]

Confirmation of Diagnosis and Stage

Clinical trials for small intestine adenocarcinoma require tissue confirmation of the cancer through biopsy results examined by a pathologist. The trial may specify that only patients with adenocarcinoma can participate, excluding other types of small intestine cancer such as neuroendocrine tumors or lymphomas.^[3][8]

Most trials also require detailed staging information to understand how advanced the cancer is. This typically involves imaging tests such as CT scans, MRI scans, or PET scans to determine whether the cancer is localized, has spread to nearby lymph nodes, or has metastasized to distant organs. Some trials may only accept patients with advanced or metastatic disease, while others might focus on earlier-stage cancers.^[12]

Performance Status and Overall Health

Clinical trials often assess a patient’s overall ability to function and carry out daily activities, referred to as performance status or functional status. This helps researchers understand whether a patient is well enough to tolerate the treatment being tested. Doctors may use standardized scales to rate how well patients can perform everyday tasks, from being fully active to being bedridden.^[12]

Blood tests are commonly required to ensure that a patient’s major organs, particularly the liver, kidneys, and bone marrow, are functioning adequately. Abnormal blood test results might indicate that certain organs are not working well enough to safely process the investigational treatment. For example, liver function tests and kidney function tests help ensure these organs can handle medications. A complete blood count checks that the bone marrow is producing enough blood cells, which is important for healing and fighting infections.^[15][21]

Molecular and Genetic Testing

Some modern clinical trials test treatments that target specific genetic changes or molecular features of cancer cells. In these cases, additional specialized testing on tumor tissue may be required to determine whether the patient’s cancer has the particular genetic mutation or biomarker that the trial treatment is designed to target. This type of testing, called molecular profiling or tumor profiling, examines the cancer’s genetic makeup to find specific abnormalities that might respond to targeted therapies.^[12]

For instance, if a trial is testing a drug that works against cancers with a specific gene mutation, only patients whose tumors carry that mutation would be eligible to participate. This approach, sometimes called precision medicine, aims to match the right treatment to the right patient based on the unique characteristics of their cancer.^[12]

Imaging and Measurement Requirements

Clinical trials often require baseline imaging scans before treatment begins so that researchers can measure the size and extent of tumors. These initial scans serve as a reference point to compare with scans taken later during the trial to see if the treatment is shrinking the tumors or slowing their growth. Trials typically use standardized criteria for measuring tumors and defining treatment response.^[12]

Previous Treatment History

Some clinical trials are designed for patients who have not yet received any treatment for their cancer, while others are specifically for patients whose cancer has returned after initial treatment or who have already tried other therapies. The diagnostic workup for trial enrollment will include a review of all previous treatments received, including surgery, chemotherapy, radiation therapy, and any other interventions.^[12]

Understanding which diagnostic tests and criteria are needed for clinical trial enrollment is an important conversation to have with your healthcare team. If you are interested in participating in a clinical trial, your doctor can help you understand what additional testing might be required and whether you meet the eligibility criteria for trials that might be appropriate for your situation.